Loading…

Smoking Attributable Risk in Multiple Sclerosis

Tobacco smoke is an important modifiable environmental risk factor for multiple sclerosis (MS) risk. The population attributable fraction (AF) of MS due to smoking can be used to assess the contribution of smoking to the risk of MS development. We conducted a matched case-control study, including in...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology 2022-03, Vol.13, p.840158-840158
Main Authors: Manouchehrinia, Ali, Huang, Jesse, Hillert, Jan, Alfredsson, Lars, Olsson, Tomas, Kockum, Ingrid, Constantinescu, Cris S
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c433t-e38d8c2dc9753fd7d22004ae9dbb033d4fe473100b594b8235c429ed4e883793
cites cdi_FETCH-LOGICAL-c433t-e38d8c2dc9753fd7d22004ae9dbb033d4fe473100b594b8235c429ed4e883793
container_end_page 840158
container_issue
container_start_page 840158
container_title Frontiers in immunology
container_volume 13
creator Manouchehrinia, Ali
Huang, Jesse
Hillert, Jan
Alfredsson, Lars
Olsson, Tomas
Kockum, Ingrid
Constantinescu, Cris S
description Tobacco smoke is an important modifiable environmental risk factor for multiple sclerosis (MS) risk. The population attributable fraction (AF) of MS due to smoking can be used to assess the contribution of smoking to the risk of MS development. We conducted a matched case-control study, including individuals with MS and population-based controls. Overall, sex- and genetic risk score-stratified AF due to smoking were calculated by fitting logistic regression models. We included 9,419 individuals with MS and 9,419 population-based matched controls. At the time of MS onset 44.1% of persons with MS and 35.9% of controls ever regularly smoked of which 38.1% and 29.2% were still smoking. The overall AF was 13.1% (95%CI: 10.7 to 15.4). The AF was 10.6% (95%CI: 7.4 to 13.7) in females and 19.1% (95%CI: 13.1 to 25.1) in males. The AF was 0.6% (95%CI: 0.0 to 2) in ex-smokers. In those having human leucocyte antigen (HLA) and non-HLA risk scores above the median levels of controls, the AF was 11.4% (95%CI: 6.8 to 15.9) and 12% (95%CI: 7.7 to 16.3), respectively. The AF was 17.6% (95%CI: 10.2 to 24.9) and 18.6% (95%CI: 5.5 to 31.6) in those with HLA and non-HLA risk scores below the median levels in controls, respectively. We noticed a decline in AF in recent birth cohorts. This study indicates that at least 13% of cases of MS could be prevented through the avoidance of tobacco smoking. Considering the prevalence of MS, this represents a very large group of people in absolute number.
doi_str_mv 10.3389/fimmu.2022.840158
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_843164962253481d9e560fd09845994a</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_843164962253481d9e560fd09845994a</doaj_id><sourcerecordid>2641515051</sourcerecordid><originalsourceid>FETCH-LOGICAL-c433t-e38d8c2dc9753fd7d22004ae9dbb033d4fe473100b594b8235c429ed4e883793</originalsourceid><addsrcrecordid>eNpVUU1P3DAQtSoqQJQfwAXtsZcstmfs2BckhKBFAlUq3C0ndrZm87G1E1D_fb1kQawvHr15781oHiFnjC4BlL5oQtdNS045XyqkTKgv5JhJiQVwjgef6iNymtIzzQ81AIhDcgQCqAZKj8nFYzesQ79aXI1jDNU02qr1i98hrRehXzxM7Rg2GXisWx-HFNI38rWxbfKnu_-EPN3ePF3_LO5__bi7vrovagQYCw_KqZq7WpcCGlc6zvN467WrKgrgsPFYAqO0EhorxUHUyLV36JWCUsMJuZtt3WCfzSaGzsZ_ZrDBvAFDXBkbx5C3MgqBSdSScwGomNNeSNo4qhUKrdFmr2L2Sq9-M1V7bjtonStvUKCUPPMvZ37udN7Vvh-jbfdk-50-_DGr4cUozUsKMht83xnE4e_k02i6kGrftrb3w5QMl8gEE1SwTGUztc7XTdE3H2MYNduYzVvMZhuzmWPOmvPP-30o3kOF_8wIouM</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2641515051</pqid></control><display><type>article</type><title>Smoking Attributable Risk in Multiple Sclerosis</title><source>Open Access: PubMed Central</source><creator>Manouchehrinia, Ali ; Huang, Jesse ; Hillert, Jan ; Alfredsson, Lars ; Olsson, Tomas ; Kockum, Ingrid ; Constantinescu, Cris S</creator><creatorcontrib>Manouchehrinia, Ali ; Huang, Jesse ; Hillert, Jan ; Alfredsson, Lars ; Olsson, Tomas ; Kockum, Ingrid ; Constantinescu, Cris S</creatorcontrib><description>Tobacco smoke is an important modifiable environmental risk factor for multiple sclerosis (MS) risk. The population attributable fraction (AF) of MS due to smoking can be used to assess the contribution of smoking to the risk of MS development. We conducted a matched case-control study, including individuals with MS and population-based controls. Overall, sex- and genetic risk score-stratified AF due to smoking were calculated by fitting logistic regression models. We included 9,419 individuals with MS and 9,419 population-based matched controls. At the time of MS onset 44.1% of persons with MS and 35.9% of controls ever regularly smoked of which 38.1% and 29.2% were still smoking. The overall AF was 13.1% (95%CI: 10.7 to 15.4). The AF was 10.6% (95%CI: 7.4 to 13.7) in females and 19.1% (95%CI: 13.1 to 25.1) in males. The AF was 0.6% (95%CI: 0.0 to 2) in ex-smokers. In those having human leucocyte antigen (HLA) and non-HLA risk scores above the median levels of controls, the AF was 11.4% (95%CI: 6.8 to 15.9) and 12% (95%CI: 7.7 to 16.3), respectively. The AF was 17.6% (95%CI: 10.2 to 24.9) and 18.6% (95%CI: 5.5 to 31.6) in those with HLA and non-HLA risk scores below the median levels in controls, respectively. We noticed a decline in AF in recent birth cohorts. This study indicates that at least 13% of cases of MS could be prevented through the avoidance of tobacco smoking. Considering the prevalence of MS, this represents a very large group of people in absolute number.</description><identifier>ISSN: 1664-3224</identifier><identifier>EISSN: 1664-3224</identifier><identifier>DOI: 10.3389/fimmu.2022.840158</identifier><identifier>PMID: 35309300</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>attributable fraction ; Case-Control Studies ; Female ; Humans ; Immunology ; Male ; multiple sclerosis ; Multiple Sclerosis - etiology ; Multiple Sclerosis - genetics ; risk factor ; Risk Factors ; smoking ; Smoking - adverse effects ; Smoking - epidemiology ; tobacco ; Tobacco Smoking - adverse effects ; Tobacco Smoking - epidemiology</subject><ispartof>Frontiers in immunology, 2022-03, Vol.13, p.840158-840158</ispartof><rights>Copyright © 2022 Manouchehrinia, Huang, Hillert, Alfredsson, Olsson, Kockum and Constantinescu.</rights><rights>Copyright © 2022 Manouchehrinia, Huang, Hillert, Alfredsson, Olsson, Kockum and Constantinescu 2022 Manouchehrinia, Huang, Hillert, Alfredsson, Olsson, Kockum and Constantinescu</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c433t-e38d8c2dc9753fd7d22004ae9dbb033d4fe473100b594b8235c429ed4e883793</citedby><cites>FETCH-LOGICAL-c433t-e38d8c2dc9753fd7d22004ae9dbb033d4fe473100b594b8235c429ed4e883793</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927036/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927036/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35309300$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:149162211$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Manouchehrinia, Ali</creatorcontrib><creatorcontrib>Huang, Jesse</creatorcontrib><creatorcontrib>Hillert, Jan</creatorcontrib><creatorcontrib>Alfredsson, Lars</creatorcontrib><creatorcontrib>Olsson, Tomas</creatorcontrib><creatorcontrib>Kockum, Ingrid</creatorcontrib><creatorcontrib>Constantinescu, Cris S</creatorcontrib><title>Smoking Attributable Risk in Multiple Sclerosis</title><title>Frontiers in immunology</title><addtitle>Front Immunol</addtitle><description>Tobacco smoke is an important modifiable environmental risk factor for multiple sclerosis (MS) risk. The population attributable fraction (AF) of MS due to smoking can be used to assess the contribution of smoking to the risk of MS development. We conducted a matched case-control study, including individuals with MS and population-based controls. Overall, sex- and genetic risk score-stratified AF due to smoking were calculated by fitting logistic regression models. We included 9,419 individuals with MS and 9,419 population-based matched controls. At the time of MS onset 44.1% of persons with MS and 35.9% of controls ever regularly smoked of which 38.1% and 29.2% were still smoking. The overall AF was 13.1% (95%CI: 10.7 to 15.4). The AF was 10.6% (95%CI: 7.4 to 13.7) in females and 19.1% (95%CI: 13.1 to 25.1) in males. The AF was 0.6% (95%CI: 0.0 to 2) in ex-smokers. In those having human leucocyte antigen (HLA) and non-HLA risk scores above the median levels of controls, the AF was 11.4% (95%CI: 6.8 to 15.9) and 12% (95%CI: 7.7 to 16.3), respectively. The AF was 17.6% (95%CI: 10.2 to 24.9) and 18.6% (95%CI: 5.5 to 31.6) in those with HLA and non-HLA risk scores below the median levels in controls, respectively. We noticed a decline in AF in recent birth cohorts. This study indicates that at least 13% of cases of MS could be prevented through the avoidance of tobacco smoking. Considering the prevalence of MS, this represents a very large group of people in absolute number.</description><subject>attributable fraction</subject><subject>Case-Control Studies</subject><subject>Female</subject><subject>Humans</subject><subject>Immunology</subject><subject>Male</subject><subject>multiple sclerosis</subject><subject>Multiple Sclerosis - etiology</subject><subject>Multiple Sclerosis - genetics</subject><subject>risk factor</subject><subject>Risk Factors</subject><subject>smoking</subject><subject>Smoking - adverse effects</subject><subject>Smoking - epidemiology</subject><subject>tobacco</subject><subject>Tobacco Smoking - adverse effects</subject><subject>Tobacco Smoking - epidemiology</subject><issn>1664-3224</issn><issn>1664-3224</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVUU1P3DAQtSoqQJQfwAXtsZcstmfs2BckhKBFAlUq3C0ndrZm87G1E1D_fb1kQawvHr15781oHiFnjC4BlL5oQtdNS045XyqkTKgv5JhJiQVwjgef6iNymtIzzQ81AIhDcgQCqAZKj8nFYzesQ79aXI1jDNU02qr1i98hrRehXzxM7Rg2GXisWx-HFNI38rWxbfKnu_-EPN3ePF3_LO5__bi7vrovagQYCw_KqZq7WpcCGlc6zvN467WrKgrgsPFYAqO0EhorxUHUyLV36JWCUsMJuZtt3WCfzSaGzsZ_ZrDBvAFDXBkbx5C3MgqBSdSScwGomNNeSNo4qhUKrdFmr2L2Sq9-M1V7bjtonStvUKCUPPMvZ37udN7Vvh-jbfdk-50-_DGr4cUozUsKMht83xnE4e_k02i6kGrftrb3w5QMl8gEE1SwTGUztc7XTdE3H2MYNduYzVvMZhuzmWPOmvPP-30o3kOF_8wIouM</recordid><startdate>20220303</startdate><enddate>20220303</enddate><creator>Manouchehrinia, Ali</creator><creator>Huang, Jesse</creator><creator>Hillert, Jan</creator><creator>Alfredsson, Lars</creator><creator>Olsson, Tomas</creator><creator>Kockum, Ingrid</creator><creator>Constantinescu, Cris S</creator><general>Frontiers Media S.A</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>ZZAVC</scope><scope>DOA</scope></search><sort><creationdate>20220303</creationdate><title>Smoking Attributable Risk in Multiple Sclerosis</title><author>Manouchehrinia, Ali ; Huang, Jesse ; Hillert, Jan ; Alfredsson, Lars ; Olsson, Tomas ; Kockum, Ingrid ; Constantinescu, Cris S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c433t-e38d8c2dc9753fd7d22004ae9dbb033d4fe473100b594b8235c429ed4e883793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>attributable fraction</topic><topic>Case-Control Studies</topic><topic>Female</topic><topic>Humans</topic><topic>Immunology</topic><topic>Male</topic><topic>multiple sclerosis</topic><topic>Multiple Sclerosis - etiology</topic><topic>Multiple Sclerosis - genetics</topic><topic>risk factor</topic><topic>Risk Factors</topic><topic>smoking</topic><topic>Smoking - adverse effects</topic><topic>Smoking - epidemiology</topic><topic>tobacco</topic><topic>Tobacco Smoking - adverse effects</topic><topic>Tobacco Smoking - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Manouchehrinia, Ali</creatorcontrib><creatorcontrib>Huang, Jesse</creatorcontrib><creatorcontrib>Hillert, Jan</creatorcontrib><creatorcontrib>Alfredsson, Lars</creatorcontrib><creatorcontrib>Olsson, Tomas</creatorcontrib><creatorcontrib>Kockum, Ingrid</creatorcontrib><creatorcontrib>Constantinescu, Cris S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Manouchehrinia, Ali</au><au>Huang, Jesse</au><au>Hillert, Jan</au><au>Alfredsson, Lars</au><au>Olsson, Tomas</au><au>Kockum, Ingrid</au><au>Constantinescu, Cris S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Smoking Attributable Risk in Multiple Sclerosis</atitle><jtitle>Frontiers in immunology</jtitle><addtitle>Front Immunol</addtitle><date>2022-03-03</date><risdate>2022</risdate><volume>13</volume><spage>840158</spage><epage>840158</epage><pages>840158-840158</pages><issn>1664-3224</issn><eissn>1664-3224</eissn><abstract>Tobacco smoke is an important modifiable environmental risk factor for multiple sclerosis (MS) risk. The population attributable fraction (AF) of MS due to smoking can be used to assess the contribution of smoking to the risk of MS development. We conducted a matched case-control study, including individuals with MS and population-based controls. Overall, sex- and genetic risk score-stratified AF due to smoking were calculated by fitting logistic regression models. We included 9,419 individuals with MS and 9,419 population-based matched controls. At the time of MS onset 44.1% of persons with MS and 35.9% of controls ever regularly smoked of which 38.1% and 29.2% were still smoking. The overall AF was 13.1% (95%CI: 10.7 to 15.4). The AF was 10.6% (95%CI: 7.4 to 13.7) in females and 19.1% (95%CI: 13.1 to 25.1) in males. The AF was 0.6% (95%CI: 0.0 to 2) in ex-smokers. In those having human leucocyte antigen (HLA) and non-HLA risk scores above the median levels of controls, the AF was 11.4% (95%CI: 6.8 to 15.9) and 12% (95%CI: 7.7 to 16.3), respectively. The AF was 17.6% (95%CI: 10.2 to 24.9) and 18.6% (95%CI: 5.5 to 31.6) in those with HLA and non-HLA risk scores below the median levels in controls, respectively. We noticed a decline in AF in recent birth cohorts. This study indicates that at least 13% of cases of MS could be prevented through the avoidance of tobacco smoking. Considering the prevalence of MS, this represents a very large group of people in absolute number.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>35309300</pmid><doi>10.3389/fimmu.2022.840158</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1664-3224
ispartof Frontiers in immunology, 2022-03, Vol.13, p.840158-840158
issn 1664-3224
1664-3224
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_843164962253481d9e560fd09845994a
source Open Access: PubMed Central
subjects attributable fraction
Case-Control Studies
Female
Humans
Immunology
Male
multiple sclerosis
Multiple Sclerosis - etiology
Multiple Sclerosis - genetics
risk factor
Risk Factors
smoking
Smoking - adverse effects
Smoking - epidemiology
tobacco
Tobacco Smoking - adverse effects
Tobacco Smoking - epidemiology
title Smoking Attributable Risk in Multiple Sclerosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T10%3A59%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Smoking%20Attributable%20Risk%20in%20Multiple%20Sclerosis&rft.jtitle=Frontiers%20in%20immunology&rft.au=Manouchehrinia,%20Ali&rft.date=2022-03-03&rft.volume=13&rft.spage=840158&rft.epage=840158&rft.pages=840158-840158&rft.issn=1664-3224&rft.eissn=1664-3224&rft_id=info:doi/10.3389/fimmu.2022.840158&rft_dat=%3Cproquest_doaj_%3E2641515051%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c433t-e38d8c2dc9753fd7d22004ae9dbb033d4fe473100b594b8235c429ed4e883793%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2641515051&rft_id=info:pmid/35309300&rfr_iscdi=true